Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-14

Clinical Trial Update: Evaluating the Safety, Pharmacokinetics and Haemodynamic Effect of a Slow Release Oral Formulation of Milrinone [Phase 1, Phase 2]

View source ↗

Summary

This study reports safety, pharmacokinetics, and haemodynamic effects of a slow-release oral milrinone formulation. It included healthy volunteers and heart fai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milrinone (milrinone)

Snippet

Sponsor: The Alfred | Conditions: Healthy, Heart Failure | Phase 1, Phase 2 | Status: COMPLETED